Medicinski Kisik Sol

Oxygen, the active ingredient in Medicinski Kisik Sol, is a medical gas presented as a medical gas for inhalation use. It provides supplemental oxygen to increase tissue oxygenation and support cellular respiration in patients with impaired gas exchange. GNH USA supplies Medicinski Kisik Sol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Medicinski Kisik Sol delivers supplemental oxygen and is used in various respiratory and emergency care settings. - Acute hypoxemic respiratory failure: improves arterial oxygen saturation and reduces work of breathing. - Chronic obstructive pulmonary disease (COPD) exacerbations: alleviates hypoxia and supports ventilation. - Peri‑operative oxygen therapy: maintains adequate oxygen levels during anesthesia and surgery. - Carbon monoxide poisoning (adjunct): accelerates displacement of carbon monoxide from hemoglobin. - Neonatal resuscitation: provides essential oxygen to newborns with compromised breathing.

Supplemental oxygen can be associated with a range of adverse reactions, most of which are related to the delivery method or excessive exposure.

Common Side Effects: - Nasal dryness or irritation - Throat discomfort or cough - Headache - Dizziness or light‑headedness - Mild fatigue

Serious or Rare Side Effects: - Pulmonary oxygen toxicity (e.g., atelectasis, fibrosis) - Central nervous system toxicity, including seizures - Retinopathy of prematurity in neonates - Fire or explosion risk when used near open flames - Severe hypoxemia rebound if abruptly discontinued at high flow rates

When using Medicinski Kisik Sol, clinicians should follow safety and monitoring guidelines to minimize risks. - Assess patient oxygen saturation before initiating therapy: ensure need for supplemental oxygen. - Avoid high flow rates in COPD patients at risk of CO₂ retention: titrate to target SpO₂. - Monitor for signs of hyperoxia: watch for respiratory distress or altered mental status. - Use flame‑resistant equipment and keep away from ignition sources: prevent fire hazards. - Ensure adequate ventilation in treatment areas: reduce accumulation of oxygen. - Store at ambient temperature: keep cylinder upright, protect from heat and direct sunlight.

Oxygen therapy can interact with other agents or environmental factors, influencing safety and efficacy.

Major Interactions (Avoid): - Nitrous oxide or other flammable anesthetic gases: increase fire risk. - Open flames or smoking: potentiate combustion hazards. - Certain high‑concentration oxygen delivery systems with incompatible materials: risk of equipment failure.

Moderate Interactions (Monitor Closely): - Bronchodilators (e.g., albuterol): may enhance oxygen uptake, requiring flow adjustment. - Sedatives or opioids: can deepen respiratory depression, necessitate closer monitoring. - Diuretics: may affect fluid balance and electrolyte status during prolonged oxygen therapy.